SCHEMBL7206966

SCHEMBL7206966

BrCC/C=C1\c2ccc(Br)cc2OCc2ncccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 5/20 0.46
CCR1 P32246 2/20 0.37
CHRM2 P08172 2/20 0.37
CCR5 P51681 1/20 0.37
MAPK14 Q16539 3/20 0.37
HRH1 P35367 3/20 0.34
KCNH2 Q12809 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 2/20 0.34
TSHR P16473 2/20 0.34
SLC22A1 O15245 1/20 0.34
CHRM4 P08173 1/20 0.34
HTR1A P08908 1/20 0.34
CHRM5 P08912 1/20 0.34
ADRA2A P08913 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206969 1.00 HTR2B (0.46) HTR2BCCR1CHRM2CCR5MAPK14
SCHEMBL7206976 0.87 HTR2B (0.46) HTR2BCCR1CHRM2CCR5MAPK14
SCHEMBL995810 0.87 HTR2B (0.46) HTR2BCCR1CHRM2CCR5MAPK14
SCHEMBL995811 0.87 HTR2B (0.46) HTR2BCCR1CHRM2CCR5MAPK14
SCHEMBL653968 0.82 HTR2B (0.62) HTR2BCHRM2HRH1KCNH2ALDH1A1
SCHEMBL653969 0.82 HTR2B (0.62) HTR2BCHRM2HRH1KCNH2ALDH1A1
SCHEMBL654984 0.81 CCR1 (0.42) CCR1CHRM2CCR5HRH1ALDH1A1
SCHEMBL7210953 0.81 CCR1 (0.42) CCR1CHRM2CCR5HRH1ALDH1A1
SCHEMBL654983 0.81 CCR1 (0.42) CCR1CHRM2CCR5HRH1ALDH1A1
SCHEMBL7210858 0.78 ALDH1A1 (0.42) HTR2BCCR1CHRM2CCR5HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613905-B1 Treating or preventing a disease associated with aberrant leukocyte recruitment and/or activation MILLENNIUM PHARMACEUTICALS, INC. 2003-09-02 US disclosed